• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估复发性疾病风险患者的系列癌症标志物研究。

Evaluating serial cancer marker studies in patients at risk of recurrent disease.

作者信息

Gail M H

出版信息

Biometrics. 1981 Mar;37(1):67-78.

PMID:7248444
Abstract

The proportional hazards model of Cox (1972, Journal of the Royal Statistical Society, Series B 34, 187--220), with a time-dependent covariate, is used to analyze serial cancer marker data. A particular advantage of this method is the case with which missing marker data are handled. Analysis of a real data set shows that high levels of the cancer marker carcinoembryonic antigen (CEA) are associated with increased risk of death in patients with resected colorectal cancer. Several aspects of CEA marker history are analyzed, including CEA level at death time t, CEA level 200 days prior to time t, and whether or not CEA exceeded 5 ng/ml prior to t. Methods to test the hypothesis of no marker effect and to give estimates and confidence intervals for model parameters are outlined both for continuous and for grouped time-to-response data. For grouped data a likelihood ratio test of the proportional hazards assumption is suggested.

摘要

采用带有时间依存性协变量的Cox比例风险模型(1972年,《皇家统计学会学报》,B辑第34卷,第187 - 220页)对系列癌症标志物数据进行分析。该方法的一个特别优势在于处理缺失标志物数据的情形。对一个实际数据集的分析表明,癌胚抗原(CEA)水平较高与接受过手术的结直肠癌患者死亡风险增加相关。分析了CEA标志物历史的几个方面,包括死亡时间t时的CEA水平、时间t前200天的CEA水平以及在t之前CEA是否超过5 ng/ml。针对连续型和分组的反应时间数据,概述了检验无标志物效应假设以及给出模型参数估计值和置信区间的方法。对于分组数据,建议进行比例风险假设的似然比检验。

相似文献

1
Evaluating serial cancer marker studies in patients at risk of recurrent disease.评估复发性疾病风险患者的系列癌症标志物研究。
Biometrics. 1981 Mar;37(1):67-78.
2
A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.一项关于癌胚抗原血水平在监测结直肠癌病程中可靠性的研究。
Clin Oncol. 1984 Jun;10(2):141-7.
3
[Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].[结直肠癌中的癌胚抗原(CEA)。一种不敏感的标志物,可在随访中排除]
Lakartidningen. 1997 Apr 30;94(18):1716-8.
4
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?癌胚抗原水平在结直肠癌的治疗管理中有价值吗?
Surgery. 1981 Mar;89(3):290-5.
5
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.结直肠癌中癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)血清水平预后价值的多变量分析
Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.
6
Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.术前癌胚抗原水平:结直肠癌患者的一项预后检测指标
Am Surg. 1980 Aug;46(8):449-52.
7
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.组织蛋白酶B和癌胚抗原在结直肠癌患者血清中的预后价值。
Clin Cancer Res. 1998 Jun;4(6):1511-6.
8
Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.癌胚抗原用于检测结直肠癌根治性切除术后的复发疾病。
Anticancer Res. 2000 Nov-Dec;20(6D):4953-5.
9
[Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy].[复发性胃肠道癌患者血清癌胚抗原倍增时间及其与肿瘤生物学和预期寿命的关系]
Gan To Kagaku Ryoho. 1998 Apr;25 Suppl 3:464-8.
10
Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.癌胚抗原和CA19-9:组织中定量标志物测量对结直肠癌预后的影响
Cancer Detect Prev. 2001;25(4):344-51.

引用本文的文献

1
REDACS: Regional emergency-driven adaptive cluster sampling for effective COVID-19 management.REDACS:用于有效管理新冠疫情的区域应急驱动自适应整群抽样
Stoch Anal Appl. 2023;41(3):474-508. doi: 10.1080/07362994.2022.2033126. Epub 2022 Feb 25.
2
A modified risk set approach to biomarker evaluation studies.一种用于生物标志物评估研究的改良风险集方法。
Stat Biosci. 2016 Oct;8(2):395-406. doi: 10.1007/s12561-016-9166-8. Epub 2016 Aug 22.
3
Blood CEA levels for detecting recurrent colorectal cancer.用于检测复发性结直肠癌的血液癌胚抗原水平。
Cochrane Database Syst Rev. 2015 Dec 10;2015(12):CD011134. doi: 10.1002/14651858.CD011134.pub2.
4
Body fat and breast cancer risk in postmenopausal women: a longitudinal study.绝经后女性的体脂与乳腺癌风险:一项纵向研究。
J Cancer Epidemiol. 2013;2013:754815. doi: 10.1155/2013/754815. Epub 2013 Apr 7.
5
Body mass index and risk of lung cancer among never, former, and current smokers.体重指数与从不吸烟者、曾经吸烟者和当前吸烟者肺癌风险的关系。
J Natl Cancer Inst. 2012 May 16;104(10):778-89. doi: 10.1093/jnci/djs179. Epub 2012 Mar 27.
6
A longitudinal study of serum insulin and glucose levels in relation to colorectal cancer risk among postmenopausal women.一项关于绝经后妇女血清胰岛素和葡萄糖水平与结直肠癌风险关系的纵向研究。
Br J Cancer. 2012 Jan 3;106(1):227-32. doi: 10.1038/bjc.2011.512. Epub 2011 Nov 29.
7
A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women.一项关于代谢综合征与绝经后妇女结直肠癌风险的纵向研究。
Eur J Cancer Prev. 2012 Jul;21(4):326-32. doi: 10.1097/CEJ.0b013e32834dbc81.
8
A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.一项关于代谢综合征与绝经后乳腺癌风险的纵向研究。
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2046-53. doi: 10.1158/1055-9965.EPI-09-0235. Epub 2009 Jun 30.
9
Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women.绝经后女性血清类胡萝卜素、视黄醇和生育酚浓度与乳腺癌风险关系的纵向研究。
Am J Clin Nutr. 2009 Jul;90(1):162-9. doi: 10.3945/ajcn.2009.27568. Epub 2009 May 27.
10
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.在五项国家外科辅助乳腺和肠道项目(NSABP)关于淋巴结阴性乳腺癌的方案中,接受保乳治疗的患者同侧乳腺肿瘤复发及局部区域复发后的预后情况。
J Clin Oncol. 2009 May 20;27(15):2466-73. doi: 10.1200/JCO.2008.19.8424. Epub 2009 Apr 6.